Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,131.42 +6.15 (+0.55%)

Official Closing Price Updated: 7:00 PM EDT, Jun 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Micron Makes the $1 Trillion Club a Little More Crowded ↗

Today 16:05 EDT

Micron has had a turnaround for the ages, going from a free cash flow negative company to a $1 trillion valuation in a little over a year.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing ↗

Today 15:35 EDT

Eli Lilly just announced a trio of acquisitions that will allow it to build a new business focused on infectious diseases.

Via The Motley Fool

Topics Intellectual Property

Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems ↗

Today 12:35 EDT

Investors are clearly worried about the safety of Pfizer's dividend, which is reasonable.

Via The Motley Fool

Topics Intellectual Property

Prediction: Eli Lilly Will Reach $1,200 in 2026 ↗

Today 10:07 EDT

International growth could help push Lilly even higher.

Via The Motley Fool

Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now? ↗

Today 9:35 EDT

Investors appear to have left Novo Nordisk behind as they focus on Eli Lilly; that could be a mistake.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support ↗

Today 8:00 EDT

The stock market appears to be rotating into health care.

Via Investor's Business Daily

Here's How Much $1000 Invested In Eli Lilly 5 Years Ago Would Be Worth Today ↗

June 05, 2026

Via Benzinga

Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors. ↗

June 05, 2026

One fund backs medical breakthroughs and charity, while the other favors industry giants and steady income. Compare their strategies and portfolio makeup.

Via The Motley Fool

Topics ETFs

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗

June 05, 2026

Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to long-term returns.

Via The Motley Fool

Topics ETFs

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors ↗

June 05, 2026

It's another step in Eli Lilly's quest to cement its lead in the chronic weight management market.

Via The Motley Fool

Why WeightWatchers (WW) Stock Is Trading Up Today

June 04, 2026

What Happened? Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 6.3% in the afternoon session after the company announced its Weight Wat...

Via StockStory

Topics Artificial Intelligence Bonds Credit Cards

AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam ↗

June 04, 2026

AbCellera Biologics (NASDAQ:ABCL) is emphasizing its transition from a partner-based antibody discovery business to a proprietary drug development company, Chief Financial Officer Andrew Booth said...

Via MarketBeat

Stock Market Today, June 4: Broadcom Drags on Nasdaq at Midday ↗

June 04, 2026

Broadcom’s weak AI-chip guidance rattled semiconductors and raised questions about tech valuations today, June 4, 2026.

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

Stay informed with the top movers within the S&P500 index on Thursday. ↗

June 04, 2026

Via Chartmill

Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies ↗

June 04, 2026

Weight Watchers joins LillyDirect for GLP-1 access as Eli Lilly signs a kidney disease research pact with Ascidian worth up to $1.9 billion.

Via Benzinga

Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success ↗

June 04, 2026

Eli Lilly knows that its GLP-1 windfall comes with an end date, so it is acting now to prepare.

Via The Motley Fool

Topics Intellectual Property

3 Reasons Eli Lilly Remains a Buy ↗

June 04, 2026

The shares are up more than 13% this year, and the pharmaceutical company has several other factors that could drive its stock higher.

Via The Motley Fool

Forget Weight Loss Drugs: Here Is Another Reason to Buy Eli Lilly Stock ↗

June 04, 2026

Eli Lilly is far from a one-trick pony.

Via The Motley Fool

Topics Intellectual Property

Elizabeth Warren Singles Out Micron, Dell And Eli Lilly As Just 3 Of The 3000+ Trades Trump Made: 'Looks Like An Absurd Level Of Corruption' ↗

June 04, 2026

Sen. Elizabeth Warren questioned Trump's trading activity, citing potential conflicts of interest and renewing calls for a stock-trading ban.

Via Benzinga

Topics Government

Avascular Necrosis Market Size, Industry Share By 2035 ↗

June 04, 2026

The most recent research report on the "Avascular Necrosis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts,

Via Talk Markets

Topics Economy

Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better ↗

June 03, 2026

Can any company pose a serious challenge to Eli Lilly in the weight-loss market?

Via The Motley Fool

Here's What I Think Is Really Going on With Novo Nordisk Stock ↗

June 03, 2026

There is light at the end of the tunnel.

Via The Motley Fool

Prediction: Eli Lilly Will Be Worth More Than SpaceX in 2 Years ↗

June 03, 2026

SpaceX looks like a rocket, but don't fly too close to the sun. Here's why Eli Lilly is likely a better stock to own.

Via The Motley Fool

Topics Initial Public Offering

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗

June 03, 2026

This particular sector may suit cautious and aggressive investors.

Via The Motley Fool

GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation

June 03, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation

June 03, 2026

Recent Industry Activity Reinforces the Need for Manufacturing Resilience, Diversified Vaccine Supply, and Health Security Amid an Evolving Global Biothreat Landscape

Via TheNewswire.com

Bull vs. Bear: The Quick Take on Viking Therapeutics Stock ↗

June 03, 2026

The pharmaceutical company's most promising drug candidate has some potential advantages over its rivals.

Via The Motley Fool

Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Year, According to Wall Street ↗

June 03, 2026

Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year.

Via The Motley Fool

Topics ETFs Intellectual Property Stocks

Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out ↗

June 03, 2026

Eli Lilly's pipeline is an embarrassment of riches.

Via The Motley Fool

Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 ↗

June 03, 2026

It is finally bouncing back after several challenging years.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.